Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...

The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.

Alkem Laboratories entered into a business transfer agreement with Rubicon Research to sell its manufacturing facility in Pithampur (Madhya Pradesh). The consideration received from the sale is Rs149 ...

Cipla Q3 Results: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from ...

Cipla share price today: The pharma major reported a 49% increase in net profit, reaching Rs 1,571 crore (Image: Reuters) Motilal Oswal has maintained a Neutral rating on Cipla, with a target ...

At the awards night, Cipla took home a total of 4 metals across categories for its impressive work and creativity. The brand won 2 silver and 2 bronze metals across categories. Apart from Cipla ...

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business.

Cipla, one of the leading pharmaceutical companies in India, released its December quarter numbers (Q3FY25) on Tuesday, January 28, reporting a 48% year-on-year (YoY) jump in its consolidated net ...

The equity benchmarks maintained their upward momentum in Thursday afternoon trading, with both the Sensex and Nifty posting gains amid mixed global cues following the US Federal Reserve’s rate ...

For Cipla Ltd, the market expert suggested the counter looked good on charts. "Investors can buy this stock at current levels. It has corrected from Rs 1,700 levels. Keep stop loss of Rs 1,340 ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...